Curative effect observation of 11 cases of primary liver cancer with obstructive jaundice treated by cyberknife
FAN Yu-ze
SUN Jing
LI Huan
SUN Ying-zhe
DUAN Xue-zhang
Abstract：Objective To evaluate the efficacy and adverse effects of stereotactic radiotherapy (cyberknife) in the treatment of primary liver cancer patients with obstructive jaundice.Methods Cyberknife for 11 cases of primary liver cancer patients with obstructive jaundice were conducted. A total of 48~50 Gy was continuously delivered to planning target volume with single dose of 5~7 Gy and 7 to 10 fractions. The combined treatment of percutaneous transhepatic cholangio-drainage or endoscopic retrograde cholangiopancreatography was conducted for two patients with TBIL>300μmol/L before radiotheraphy.Results These patients were followed up for 12 to 28 months after cyberknife treatment. Twelve months after the treatment, the tumor control rate was 81.8%, and clinical benefit rate was 81.8%. The survival rate was 81.8%. The related clinical indicators such as TBIL, ALT, ALP, GGT were significantly improved.Conclusions The treatment of liver cancer with obstructive jaundice by cyberknife has a high tumor control rate with significant decrease of serum bilirubin, exact curative effect and small adverse reaction.
Keywords：primary liver cancerobstructive jaundicecyberknifestereotactic radiotherapy
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 99-103 )